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Current guidelines, and most of the literature, rely in complex 
algorithms, which can be very difficult to follow in a busy 
trauma center. Our main focus is to create and implement an 
evidence-based protocol for DVT/VTE prophylaxis which is 
simple and easy to follow, and study the effects of a simpler 
protocol on the rates of compliance with DVT/VTE prophylaxis. 
Despite advances in the management of major trauma 
patients, deep vein thrombosis/venous thromboembolism 
(DVT/VTE) continues to prolong hospitalization, increase 
treatment costs, and contribute to morbidity and mortality. 
The DVT prophylaxis of trauma patients is a complex problem 
since many are very high risk for DVT, have a high bleeding 
risk, and have multiple dressings and orthopedic fixation 
devices precluding the use of DVT prophylactic agents.
VTE in trauma patients is a widely recognized problem. 
Trauma patients are a higher risks for VTE than the rest of 
the population. How soon to implement VTE prophylaxis, 
which agents to use, and for how long are some of the many 
questions highly debated in this patient population. Also, 
the complexity of current guidelines and protocols make 
it very difficult to implement and follow. Most evidence-
based protocols that exist require to follow some sort of 
embolic scoring system, account for multiple risk factors, 
and assigning a numeric value to each to obtain a final score, 
which dictates the appropriate DVT prophylaxis. 
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Problem Statement
 
The new protocol was finished and presented to multiple departmental 
reviews, and currently awaits formal review and approval. Pre-implementation 




Due to lack of results to discuss, this section is limited to our expectations of 
the protocol. With this guideline, we anticipate earlier start, and higher rates of 
compliance with DVT/VTE prophylaxis guidelines in trauma patients.
Also, this protocol emphasizes the importance of extending DVT/VTE 
prophylaxis 8-12 weeks after discharge in certain patient populations. We 
anticipate this protocol will change the way we manage DVT/VTE prophylaxis 
after discharge from the hospital.
Conclusion & Future
 This was a mixed study. We conducted a literature review of PubMed, Cochrane, various journals including the Journal of 
Trauma and Acute Care Surgery, Journal of Neurosurgery and 
Spine. We included papers within the last 10 years, utilizing 
the following key words alone and in combination:  DVT, 
thromboembolism, prophylaxis, and trauma. 
 New protocol was created, which underwent multiple 
departmental revisions, and is pending final approval. After 
final approval is obtained, it will be piloted in patients with 
blunt trauma, with or without solid organ injuries. We will 
exclude any patient with orthopedic injuries and head trauma.
 A retrospective chart review will be conducted using 
the Electronic Health System. Data points will be collected 
on patients with blunt trauma, with or without solid organ 
injury, and will include: time to start of DVT prophylaxis, 
type of prophylactic agent used, and anticoagulation plan at 
discharge. 
Methods
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1- Orthopedics:  Refer to attachment D (Modified Innsbruck Algorithm for 
anticoagulation in Orthopedic Injury) 
 Begin mechanical VTE prophylaxis on admission until discharge unless 
there is a contraindication. 
 If surgery is not anticipated, or anticipated but greater than 6 hours after 
the first scheduled anticoagulation dose, Start VTE prophylaxis in the ED.  
There is NO need to hold VTE prophylaxis. 
 Current literature favors thromboprophylaxis with Rivaroxaban, or LMWH 
if patient cannot tolerate PO (last dose up to 12h preop).  
 If surgery is anticipated within 6-12 hours, consider UFH for 
thromboprophylaxis, last dose 4-6 hours pre-op. 
 If surgery is anticipated within 6 hours of the first scheduled 
anticoagulation dose, do not administer VTE prophylaxis until after the 
surgical intervention is completed.  
 After surgical intervention is completed, initiate VTE prophylaxis with 
Rivaroxaban 6-10h post op in patients able to tolerate PO (favored by 
current literature). If patient cannot tolerate PO, use LMWH 12-24 hours 
post op.  
 
2- Blunt head trauma: Refer to attachment C (Parkland Protocol's Modified 
Berne-Norwood Criteria). 
 Begin mechanical VTE prophylaxis on admission until discharge unless 
there is a contraindication. 
 In low risk TBI patients, initiate Enoxaparin at 24 hours post-injury. 
 In moderate risk TBI, initiate Enoxaparin at 72 hours post-injury if CT scan 
stable for 24 hours. 
 In High risk TBI, consider prophylactic IVC filter placement. 
 
3- Blunt Solid Abdominal Organ injury: 
 Begin mechanical VTE prophylaxis on admission until discharge unless 
there is a contraindication. 
 Pharmacologic thromboprophylaxis may be initiated provided the patient 
has no documented intra-abdominal hematoma. 
 Patients ongoing non-operative management, with any degree of 
hemorrhage, initiate VTE chemoprophylaxis after 24 hours with no 
evidence of ongoing hemorrhage or coagulopathy on lab exam 
(PT/PTT/INR/platelet assay). 
 Patients ongoing surgical management, start chemoprophylaxis with 









III.  SCOPE: 
These guidelines were prepared by the Department of Surgical Education, 
Lehigh Valley Health Network. They are focused on the adult trauma patient (>15 
yrs) requiring venous thromboembolism prophylaxis due to trauma admission, 
pre-existing conditions, or co-morbid conditions. They are based upon the most 
recent available medical literature and clinical expertise at the time of 
development. They are not intended to replace clinical judgement or dictate 
patient care, the attending physician and collaborating specialty consultants 
determine the need for VTE prophylaxis. 
 
IV. INTERVENTION/GUIDELINE: 
1.  On admission, each trauma patient’s risk for VTE will be assessed by 
attending physician and collaborating specialty consultants. Refer to Attachment 
B (Trauma Embolic Scoring System) or Attachment C (Risk Assessment Profile) 
for risk assessment tools. Reassess as clinically indicated.  Symptoms would 
include new onset of pain with lower or upper extremity swelling not due to 
fracture. 
 
VTE documentation must be written with initial physician order of 
anticoagulant.  Daily VTE’s should be documented in Progress Notes or 
using the electronic documentation system by the rounding provider.  
 
2.  Sequential compression devices (SCD) should be placed on both lower 
extremities.  If both lower extremities are unavailable, place on ANY available 
extremity including upper.  Consider AV impulse foot pumps for pts with 
orthopedic devices &/or dressings precluding SCD’s. 
3.  BLEEDING RISK: Assessed by the Trauma Team daily.  Consensus 
guidelines developed by our multi- disciplinary trauma group recommends 
starting anticoagulation therapy as soon as possible.  Regarding specific injuries, 
discussion with the appropriate consulting service will occur to identify the start 
date for prophylaxis. 
  
4.  Duplex Scan will only be performed if symptomatic, not for routine screening 
purposes.  If the Duplex Scan is positive for Deep Venous Thrombosis: 
 
a. A report of a clot and the location will be called to the unit, trauma 
resident or trauma Advanced Practice Clinician with prompt notification of 
the Trauma Team Leader. 
 
b. Bleeding risk is identified as per section #3 above 
 
c. In selected patients with good cardiopulmonary reserve, may elect to 
follow symptomatic below knee clot until patient can be anticoagulated 
rather than place IVC filter.  Patient must be screened weekly to rule 
out clot extension. 
 
d. In selected patients with low cardiopulmonary reserve, high bleeding 




4- Spinal cord injury with deficits: 
 Pharmacologic prophylaxis may be initiated provided the patient has NO 
documented spinal cord epidural hematoma, NO evidence of active 
bleeding, NO evidence of a head injury, and NO coagulopathy on lab 
exam. 
 If CT scan or MRI shows contusion with obvious blood, Low Molecular 
Weight Heparin should be held. 
 If surgery is anticipated within 6 hours, do not anticoagulate. 
 If surgery is anticipated, but in over 6 hours, begin VTE chemoprophylaxis 
in the ED. Literature favors LMWH over UFH due to lower risk of bleeding, 
last dose 12 hours prior to surgery.  
 Consider UFH if surgery within 6-12 hours, last dose 4-6 hours prior to 
surgery. 
 After surgical intervention is completed, initiate VTE prophylaxis with 
LMWH 12-24 hours post op. 
 
 
CONSIDERATIONS FOR PROPHYLACTIC WARFARIN 
Low Molecular Weight Heparin can be converted to Warfarin as soon as pt 
tolerating PO or Tube Feeds and patient has no planned surgery in next 3-5 days.  
Warfarin is generally started at 5mg po daily and adjusted to target INR, 2.5; 
range, 2 to 3. Give Low Molecular Weight Heparin and Warfarin concurrently to 
INR > 2 for two consecutive days then D/c Low Molecular Weight Heparin.  
 
V. IMPLEMENTATION PROCESS AND MONITORING: 
 For major trauma patients at high risk for VTE, mechanical prophylaxis with 
SCDs should be provided as soon as possible unless contraindicated by 
lower & upper-extremity injury.  
 Pharmacologic prophylaxis should be added to mechanical prophylaxis as 
soon as possible unless precluded by bleeding risk.  
 Daily reevaluation of risks versus benefits should be weighed during daily 
multidisciplinary trauma rounds to allow initiation or discontinuation of DVT 
prophylaxis as appropriate.  
 While IVC filter should not be used for primary VTE prevention in most major 
trauma patients, consideration is reasonable in select high risk patients who 
are unable to receive pharmacologic prophylaxis for an extended period. 
 Rates of DVT are monitored and all patients with a reported DVT are 
discussed and reviewed during weekly process improvement meetings. 
  
The duration that VTE prophylaxis should be maintained is difficult to determine 
in high risk patients.  There is evidence to support the extension of prophylaxis 
for 8 to 12 weeks in certain patient populations, i.e. hip surgery and spinal cord 
injury patients.  In fact, 20 to 55% of PE occurs more than 1 week after surgery 
and about 15% of PE occurs more than 30 days after surgery.   
 
VI. EVIDENCE: 
